• Circle Pharma Announces Nomination of CID-165, an Oral First-in-class Cyclin D1 RxL Inhibitor, as Development Candidate for its Second Oncology Program

  December 19, 2025 9:16 am

• Oncologist shares 5 evidence-based strategies catered to Indian lifestyles to lower the risk of colorectal cancer | Health

  December 19, 2025 8:04 am

• Revolutionizing Cancer Testing With ddPCR

  December 19, 2025 7:22 am

• University of Chicago Extends Collaboration with AbbVie to Advance Clinical Research and Patient Outcomes in Oncology

  December 19, 2025 7:05 am

• Promoting CAR T Access Focuses on Awareness, Capacity, and Economics

  December 19, 2025 6:29 am

• Promoting CAR T Access Focuses on Awareness, Capacity, and Economics

  December 19, 2025 5:34 am

• Journal launch enables oncology education and quality improvement

  December 18, 2025 2:41 pm

• 26th Multidisciplinary Management of Cancers: A Case-Based Approach

  December 18, 2025 2:38 pm

• Karmanos Cancer Institute Adds Choucair to Thoracic Oncology Team

  December 18, 2025 2:34 pm

• Siddhartha Mukherjee: Metabolism is the next frontier in cancer treatment

  December 18, 2025 1:29 pm